2004
DOI: 10.1038/sj.onc.1207985
|View full text |Cite
|
Sign up to set email alerts
|

Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions

Abstract: Budesonide, a glucocorticoid, was proven to be a highly effective agent in preventing the development of lung tumors in A/J mice. In a lung tumor bioassay, budesonide produced 70% inhibition of tumor multiplicity and 94% reduction of total tumor load compared to benzopyrene (B[a]P) treated mice. Gene expression array analysis was performed on mouse lung tumors from this bioassay using Affymetrix U74Av2 GeneChips to determine gene expression changes associated with budesonide treatment. We found 363 genes that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
41
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 47 publications
(42 citation statements)
references
References 20 publications
1
41
0
Order By: Relevance
“…Furthermore, in some tissues including skin, glucocorticoids act as potent tumor suppressors (Schwartz et al, 1977;Verma et al, 1983;Yao et al, 2004). We found that the expression of GR is decreased in experimentally induced skin tumors in SENCAR mice especially during the early stages of skin carcinogenesis (Budunova et al, 1997).…”
Section: Discussionmentioning
confidence: 78%
“…Furthermore, in some tissues including skin, glucocorticoids act as potent tumor suppressors (Schwartz et al, 1977;Verma et al, 1983;Yao et al, 2004). We found that the expression of GR is decreased in experimentally induced skin tumors in SENCAR mice especially during the early stages of skin carcinogenesis (Budunova et al, 1997).…”
Section: Discussionmentioning
confidence: 78%
“…One of the difficulties in evaluating the efficacy of a chemopreventive agent is the lack of biomarkers that could ultimately be assessed not only in the animal model but also in human clinical trials. Although most chemopreventives act by affecting multiple signaling pathways to cause growth arrest and/or apoptosis, we and others have asked whether agents that cause the reexpression of tumor suppressor genes silenced by methylation could be an effective approach for reversing preinvasive disease or blocking cancer progression (5). Silencing of genes by promoter hypermethylation is now recognized as a crucial component in lung cancer initiation and progression, making it an attractive target for prevention (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…Budesonide is a glucocorticoid, a family of compounds that are effective cancer chemopreventive agents in animal models but can have side effects in humans (24). Several studies showed that budesonide, given either in diet or by aerosol, inhibits the formation of lung tumors in the lung of mice treated either with benzo(a)pyrene (24)(25)(26)(27)(28)(29)(30) or vinyl carbamate (31). In addition, budesonide was found to modulate gene expression during mouse lung tumorigenesis (28).…”
mentioning
confidence: 99%
“…Several studies showed that budesonide, given either in diet or by aerosol, inhibits the formation of lung tumors in the lung of mice treated either with benzo(a)pyrene (24)(25)(26)(27)(28)(29)(30) or vinyl carbamate (31). In addition, budesonide was found to modulate gene expression during mouse lung tumorigenesis (28). PEITC is a naturally occurring isothiocyanate contained in watercress (Nasturtium officinale), which has been shown to inhibit lung tumors induced in mice and rats by NNK (32)(33)(34)(35)(36), whose metabolic activation is blocked by PEITC (34).…”
mentioning
confidence: 99%